Sepsis

Inflammatix cracks the code of sepsis with an AI-powered test that outperforms the standard of care

The Today's Clinical Lab 2025 Pathogen Detection & Infectious Disease print issue features smarter diagnostics, reemerging threats, and lab-driven strategies for tackling sepsis, measles, and C. difficile infections

FDA-approved tests like Intellisep and TriVerity™ demonstrate potential for early sepsis diagnosis

Sepsis remains elusive without a definitive test. A breakthrough in host response diagnostics may finally close the gap

QuickMIC® is an ultrarapid antimicrobial susceptibility testing (AST) system designed to provide critical results for sepsis patients

IntelliSep is the first and only FDA-cleared cellular host diagnostic indicated for use in the ED

First-time attendee explores new technologies and future solutions at the Association for Diagnostics in Laboratory Medicine Annual Lab Expo

Researchers are testing a new technology to diagnose bacteremia in newborn babies

The test may prevent clinicians from relying solely on their judgement to treat a patient presenting sepsis symptoms

As many as 80 percent of deaths due to sepsis could be avoided through rapid diagnosis and treatment